Results 191 to 200 of about 3,128,729 (335)

Patient-Reported Outcomes After Single-Stage Spiral Preputial Graft Urethroplasty for Panurethral Strictures: A Single-Centre Prospective Study [PDF]

open access: gold
Saurabh Thakkar   +6 more
openalex   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Validating Patient-Reported Outcomes and Surveys in Other Languages. [PDF]

open access: yesCurr Rev Musculoskelet Med
Kwok VE, Diaz A, Grellinger E, Swarup I.
europepmc   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Reimagining patient-reported outcomes in the age of generative AI. [PDF]

open access: yesNPJ Digit Med
Boyer L   +4 more
europepmc   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Sex Differences in Patient-Reported Outcomes Among People Living With HIV Switching to an Oral Dual Therapy: Results From the PROBI Study

open access: yesAIDS Research and Treatment
Tristan Alain   +9 more
doaj   +1 more source

Characterizing sleep-related phenotypes with patient-reported outcomes in Parkinson's disease. [PDF]

open access: yesFront Aging Neurosci
Grover S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy